布拉丁A通过向SIRT6抑制质瘤细胞的生长
Zhi Wang1,2, Yushuai Zhu1,2, Can Luo1,2
1Department of Cerebrovascular Disease, Hainan General Hospital, Hainan Affiliated Hospital of Hainan Medical University, Haikou, Hainan 570311, PR China.
Heliyon
|January 23, 2025
概括
布拉丁A (BLA) 通过抑制癌细胞增殖和诱导亡,显示出治疗恶性质瘤的潜力. 这种二类类化合物向SIRT6,为脑瘤提供了有前途的治疗途径.
科学领域:
- 神经瘤学神经瘤学
- 分子生物学分子生物学
- 药理学 药理学是指药理学的学科.
背景情况:
- 质瘤是预后不佳的原发性脑瘤,需要新的治疗策略.
- 目前的化疗等治疗方法对高度恶性质瘤的疗效有限.
研究的目的:
- 为了研究布拉丁A (BLA) 的抗瘤作用.
- 阐明BLA在人类质母细胞瘤细胞中的作用的分子机制.
主要方法:
- 使用U87MG和U251质母细胞瘤细胞系进行了体外研究.
- 评估细胞增殖,生存,细胞亡,细胞循环和蛋白质表达.
- 基因素乙化和SIRT6活性分析.
- 进行SIRT6淘汰实验以确认机制.
主要成果:
- BLA以剂量依赖的方式抑制了质母细胞瘤细胞增殖和存活率.
- 通过调节酶和Bcl-2家族蛋白质,BLA诱导了亡.
- BLA导致G2/M细胞周期停止,并影响ERK/Myc通路.
- BLA抑制了基因素乙化和上调SIRT6,SIRT6对其抗质瘤作用至关重要.
结论:
- 通过抑制增殖和诱导亡,BLA表现出显著的抗质瘤活性.
- BLA的治疗作用通过SIRT6通路进行介导.
- BLA代表了潜在的新型治疗药物用于质瘤治疗.
相关概念视频
The Retinoblastoma Gene
4.0K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.0K
Abnormal Proliferation
4.4K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.4K
Inhibition of Cdk Activity
4.6K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.6K
Loss of Tumor Suppressor Gene Functions
4.7K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
4.7K
mTOR Signaling and Cancer Progression
3.7K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.7K


